IRIS
AQUARO, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.489
EU - Europa 2.604
AS - Asia 1.119
AF - Africa 125
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 5
SA - Sud America 4
Totale 8.357
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.364
UA - Ucraina 1.236
DE - Germania 640
SG - Singapore 437
CN - Cina 368
SE - Svezia 262
TR - Turchia 182
IT - Italia 148
CA - Canada 124
SN - Senegal 109
AT - Austria 88
HK - Hong Kong 88
FR - Francia 71
FI - Finlandia 69
RU - Federazione Russa 22
IN - India 21
BE - Belgio 19
GB - Regno Unito 15
EU - Europa 10
RO - Romania 7
NL - Olanda 6
ZA - Sudafrica 6
ES - Italia 5
CZ - Repubblica Ceca 4
TZ - Tanzania 4
AU - Australia 3
ET - Etiopia 3
KG - Kirghizistan 3
KR - Corea 3
AL - Albania 2
BO - Bolivia 2
GR - Grecia 2
IE - Irlanda 2
IL - Israele 2
IR - Iran 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
BR - Brasile 1
CH - Svizzera 1
CY - Cipro 1
DK - Danimarca 1
GH - Ghana 1
IQ - Iraq 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
PE - Perù 1
PK - Pakistan 1
RE - Reunion 1
Totale 8.357
Salva come PNG Salva come JPEG
Città #
Jacksonville 864
Chandler 607
Dearborn 447
Boardman 432
San Mateo 341
Singapore 310
Lawrence 186
Roxbury 182
Izmir 179
New York 135
Shanghai 129
Des Moines 118
Ottawa 111
Dakar 109
Cambridge 83
Beijing 70
Helsinki 68
Ann Arbor 66
Ashburn 65
Wilmington 65
Vienna 62
Grafing 51
Ogden 47
Brooklyn 43
Inglewood 30
Rende 26
Seattle 23
Hong Kong 22
Brussels 19
Los Angeles 17
Rome 16
Strasbourg 14
Guangzhou 11
Norwalk 10
Toronto 10
Wuhan 10
Jiaxing 8
Munich 8
Nanjing 8
Bremen 7
Florence 7
San Francisco 7
London 6
Milan 6
Pune 6
West Jordan 6
Amsterdam 5
Falkenstein 5
L’Aquila 5
Moscow 5
Shenyang 5
Brno 4
Chicago 4
Dar es Salaam 4
Haikou 4
Jinan 4
Nanchang 4
Princeton 4
St Petersburg 4
Wuxi 4
Amantea 3
Bishkek 3
Gatchina 3
Hefei 3
Houston 3
Jinhua 3
Kunming 3
Melbourne 3
Newark 3
Palermo 3
Redmond 3
Seoul 3
Athens 2
Auckland 2
Avignon 2
Bitonto 2
Cedar Knolls 2
Cellatica 2
Changsha 2
Dalian 2
Delhi 2
Dublin 2
Esslingen am Neckar 2
Falls Church 2
Frankfurt am Main 2
Hangzhou 2
Kazan' 2
La Paz 2
Madrid 2
Nuremberg 2
Paris 2
Perm 2
Perugia 2
Riyadh 2
Shenzhen 2
Taranto 2
Vientiane 2
Washington 2
Woodbridge 2
Zhengzhou 2
Totale 5.200
Salva come PNG Salva come JPEG
Nome #
1,2,3-triazole-TSAO analogues: Synthesis and anti-HIV activity 159
Carbazole Derivatives as Antiviral Agents: An Overview 105
Identification of chlorocarbazole derivatives as potential antiviral agents. 103
Progettazione, studio di docking molecolare e sintesi di nuove molecole capaci di interagire con il virus responsabile della SARS-COVID 19. 98
CCR5/CXCR4 dual antagonism for the improvement of HIV infection therapy 93
Cachrys spp. from Southern Italy: Phytochemical Characterization and JAK/STAT Signaling Pathway Inhibition 86
Apoptosis in Human Astrocytic Cells Induced by HIV-Infected Macrophages 86
ANTIBACTERIAL AND ANTIVIRAL PHARMACEUTICAL COMPOSITION 84
Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs. 80
Antiretrovirus activity of novel class of acyclic pyrimidine nucleoside phosphonates 80
Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: new evidence and future perspectives 80
Chloro-1,4-dimethyl-9H-carbazole Derivatives Displaying Anti-HIV Activity 73
Anti-HIV efficacy in primary monocyte/macrphage by phosphorylated and phosphonated derivatives of nucleside analogues 72
Antiviral activity of amprenavir in human macrophages acutely and chronically infected by HIV-1 72
Activity of masked 2’-3’-dideoxynucleoside-monophosphate derivatives against human immunodeficiency virus in resting macrophages 72
Anti-nerve Growth Factor Antibody Abrogates Macrophages-mediated HIV-1 Infection and Depletion of CD4+ T-lymphocytes in hu-SCID Mice 70
AZT treatment of HIV-1 infected macrophages prevents apoptosis and necrosis in human astrocytic cells 70
Anti-HIV activity of protease inhibitors in productively-infected macrophages and correlation with clinical outcome 70
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90. 70
Activity of GM-CSF and M-CSF upon Replication of HIV and Other DNA- and RNA-Viruses in Primary Macrophages 69
Anti-HIV activity of nucleoside analogues in mononuclear cells. Workshop on Recent advances in modified nucleosides 68
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies. 68
Activity of masked 2’-3’-Dideoxynucleoside Monophosphate Derivatives Against Human Immunodeficiency Virus in Resting Macrophages 66
Analisi mediante PCR dell’influenza di citochine sulla replicazione virale di HIV-1 e HSV-1 in macrofagi primari umani 66
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure 65
Anti-nerve growth factor Ab abrogates macrophage mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice 62
Acyclic nucleoside phosphonates: A new class of compounds with antiviral and immunomodulatory activity 62
The degree of HIV-1 amino acid variability is strictly related to different disease progression rates 61
Understanding HIV compartments and reservoirs. 60
Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics 60
Potent antiviral activity of amprenavir in primary macrophages infected by human immunodeficiency virus 59
Activity of the (R)-Enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine [(R)-PMPA] and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine [(R)-PMPDAP] against Human Immunodeficiency Virus in Different Human Cell Systems 59
Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir 58
Antiviral efficacy of inhibitors of HIV protease in chronically-infected macrophages 58
Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically-infected macrophages 57
Cyclosaligenil-2’,3’-didehydro-2’,3’ – dideoxythymidine Monophosphate: efficient Intracellular Delivery of d4TMP 57
Antiviral activity of nucleoside analogues in macrophages 57
Glutathione inhibits HIV replication by acting at late stages of virus lifecycle 57
Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives 57
Does residual virus replication during successful HAART lead to HIV-1 genetic evolution? 56
Thidiazuron: New Trends and Future Perspectives to Fight Xylella fastidiosa in Olive Trees 55
Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus 54
Influenza virus A (H5N1): a pandemic risk? 52
Attivita’ di farmaci inibitori del virus dell’immunodeficienza umana in macrofagi umani e correlazione con l’efficacia clinica 51
Therapeutic strategies towards HIV-1 infection in macrophages 51
Factors affecting the anti-HIV and anti-HSV activity of nucleoside analogues in macrophages 51
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 50
Microbiological Characteristics and Physico-chemical Parameters of Fermented Milk Product Ergo-A Traditional Yogurt Product of Ethiopia 50
Latent infection of human herpesvirus type-7 in macrophage 48
HIV-1-mediated apoptosis occurs in macrophages infected by X4, but not by R5 viruses 48
Cytokines in HIV infection 48
oxidative stress and HIV infection:target pathways for novel therapies? 47
Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A4001029. 47
The Potent Inhibition of Human Immunodeficiency Virus and Herpes Simplex Virus Type 1 by 9-(2-Phosphonylmethoxyethyl)Adenine (PMEA) in Primary Macrophages Is Determined by Drug Metabolism, Nucleotide Pools and Cytokines 47
Development of resistance to anti-HIV drugs in primary macrophages 47
Comparative antiviral activity of integrase inhibitors in human monocyte-derived macrophages and lymphocytes 46
Specific VpU codon changes were significantly associated with gp120 V3 tropic signatures in HIV-1 B-subtype. 46
Nerve growth factor in an autocrine factor essential for the survival of macrophages infected by human immunodeficiency virus 46
Studio di fattori che influenzano l’attivita’ anti-HIV ed anti-HSV di analoghi nucleosidici nei monociti-macrofagi 46
Effects of Amprenavir on HIV-1 Maturation, Production and Infectivity Following Drug Withdrawal in Chronically-Infected Monocytes/Macrophages 46
Comparative efficacy of antiviral compounds in monocytes/macrophages and lymphocytes infected by HIV 46
Le basi razionali della terapia di associazione nel trattamento dell’AIDS 45
NEUROAIDS: VIROLOGICAL ASPECTS OF HIV INFECTION 45
The contribution of peroxynitrite generation in HIV replication in human primary macrophages 45
Il macrofago e l’infezione da HIV. Ruolo delle cellule lungo sopravviventi nella patogenesi e nella terapia. 45
Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus 45
The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages 44
Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist 44
Modulazione dell’infezione da virus influenzale in macrofagi trattati con citochine 44
HIV infection in macrophage: role of long-lived cells and related therapeutical strategies 44
S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation 44
Different Patterns of HIV-1 Replication in MACROPHAGES is Led by Co-Receptor Usage 44
Highly Favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 (HIV-1) replication 43
Farmaci inibitori della replicazione di HIV nei macrofagi: Attivita’ antivirale in vitro e correlazione con l’efficacia clinica 42
Le mutazioni osservate nei macrofagi primari umani dopo trattamento con farmaci inibitori della transcrittasi inversa non conferiscono resistenza 42
The counter-current centrifugal elutriation (cee) as essential tool for purification of monocytes and the assessment of the activity of cytokines upon virus replication 42
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro 42
Razionale della terapia dell’encefalopatia da HIV-1: inibizione della replicazione virale in macrofagi 41
Macrofagi infettati da HIV provocano in vitro morte cellulare per apoptosi in cellule astrocitarie 41
M40401, un composto sod-mimetico con potente attività anti-HIV nei macrofagi, previene l’apoptosi negli astrociti 41
TAK-779 blocca il corecettore CCR5 ed inibisce fortemente la replicazione di ceppi monocitotropi di HIV, in vitro ed in vivo 41
Intracellular GSH content and HIV replication in human macrophages 40
In vitro activity of inhibitors of late stages of the replication of HIV in chronically-infected macrophages 40
Macrophages: a crucial reservoir for human immunodeficiency virus in the body 40
Modulazione della replicazione virale in macrofagi trattati con Granulocyte-Macrophage Colony Stimulating Factor 40
Viral Dynamic and mutations in the Pol Gene during primary HIV-1 infection 40
Inhibition of HIV replication in primary macrophages by antiviral drugs: Modulation by cytokines and comparative efficacy in lymphocytes 39
Phosphorylated and phosphonated derivatives of nucleoside analogues are more active against HIV in monocyte/macrophages than in lymphocytes 39
Selective targeting of antiviral compounds to macrophages via red blood cells drug delivery 39
M40401, a sod mimetic compound with a potent anti-HIV activity in macrophages, prevents apoptosis in astrocytes 39
Replication of HIV-1 and HSV-1 in macrophages: Comparative activity of acyclic nucleoside phosphonates in the presence or absence of cytokines enhancers of virus replication 39
Long lasting and efficient inhibition of HIV replication in macrophages is obtained by reverse transcriptase inhibitors and their phosphorylated- and phosphonated derivatives 39
Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4(+) T lymphocytes 39
Red-blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: efficiency, metabolism, and activity against human immunodeficiency virus or herpes simplex virus 39
CARBAZOLE DERIVATIVES TARGETING HUMAN TOPOISOMERASES I AND ACTIN IN BREAST CANCER TREATMENT 38
Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors. 38
NGF is an autocrine factor essential foe the survival of macrophages infected with HIV 37
Potent anti-HSV effect of HPMPC in resting macrophages 37
Gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure 37
HIV-infected macrophages induce apoptosis in human astrocytic cells 36
Totale 5.526
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.703
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020602 0 0 0 0 0 0 105 193 25 19 184 76
2020/20211.353 213 4 176 184 3 186 10 193 28 186 6 164
2021/20221.552 18 165 4 112 139 61 12 405 34 9 201 392
2022/20231.536 224 110 51 182 155 134 2 221 236 47 112 62
2023/2024881 88 25 56 27 46 172 21 35 107 30 46 228
2024/2025974 139 456 51 92 129 106 1 0 0 0 0 0
Totale 8.425